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Abstract Novel murine cDNAs encoding a receptor-like protein 
tyrosine phosphatase, termed Byp (HPTP beta-like tyrosine 
phosphatase) were cloned. The putative Byp protein consists of 
1238 amino acids, which possesses a single catalytic domain in 
the cytoplasmic region. The extracellular region comprises eight 
repeats of a fihronectin type III module and contains multiple 
N-glycosylation sites. The byp mRNA was 7.7-kb long and ex- 
pressed in every tissue examined, its level being high in the brain 
and kidney. Transfection of the byp cDNA expression plasmid 
into COS7 cells resulted in the expression of a 220-kDa tyrosine 
phosphorylated protein. Furthermore, co-expression of Byp and 
the Src family kinase Fyn increased the level of tyrosine phospho- 
rylation of Byp, suggesting that Byp was tyrosine-phosphorylated 
by Fyn. Finally, the byp gene was located to mouse chromosome 
2El-2 and rat chromosome 3q32-33. 
Key words: Protein tyrosine phosphatase; 
Tyrosine phosphorylation; Fyn tyrosine kinase 
1. Introduction 
Accumulating data show that protein tyrosine phosphoryla- 
tion is an important event in cell growth and differentiation, 
malignant transformation, and cytoskeletal function [I]. The 
level of tyrosine phosphorylation is determined by the opposing 
actions of protein tyrosine kinases (PTKs) and protein tyrosine 
phosphatases (PTPs). In contrast with the extensive analysis 
and information on the role of PTKs, studies on the physiolog- 
ical importance of PTPs are limited. A cytosolic PTP was first 
purified by Tonks et al. [2]. Since then, the number of PTP 
characterized has been increased steadily. Consequently, PTPs 
can now be divided into three subfamilies: (1) transmembrane, 
receptor-like PTPs (RPTPs); (2) soluble intracellular PTPs; and 
(3) dual-specificity PTPs [3]. All PTPs have at least one con- 
served catalytic domain containing an 11 -amino acid consensus 
motif (lIV)HCXAGXGR(SIT)G (X can be any amino acid). 
The cysteinyl residue within the consensus motif is essential for 
the PTP activity [4]. 
The RPTPs have highly-conserved intracellular phosphatase 
domains and extracellular domains with diverse amino acid 
sequences. The sequences of the extracellular domains share 
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sequence similarity with the cell adhesion molecules, such as 
fibronectin, N-CAM and chondroitin sulfate. Namely RPTPs 
are characterized by having fibronectin type-III (FN-III)-like 
motif, immunogloblin (Ig)-like motif, or other motifs unique to 
transmembrane proteins. Based on the amino acid sequences 
of the extracellular domains, the RPTPs can be divided into five 
classes [5,6]. Among these, type III RPTPs are characterized by 
having only FN-III-like repeats in the extracellular region. This 
motif, which was originally described in fibronectin, may medi- 
ate heterophilic interactions with ligands located on the adja- 
cent cells or the extracellular matrix [5]. Type III RPTPs include 
HPTPB [7], Drosophila DPTPlOD [8,9], SAP-l [lo], DEP-1 [11] 
or HPTPr [12], rabbit GLEPPI [13], OST-PTP [14], and PTP- 
U2 [15]. It has been reported that DEP-1 expression was in- 
creased in dense cell culture relative to sparse cell culture, and 
PTP- U2 expression was enhanced by phorbol ester, dihydroxy- 
vitamin D,, retinoic acid, and dimethyl-sulfoxide. The other 
biological function of these RPTPs remains to the character- 
ized. 
We report here the molecular cloning, gene expression, and 
chromosomal location of a new member, termed Byp (HPTP 
beta-like tyrosine phosphatase), of mouse type III RPTP fam- 
ily. The cDNA for this RPTP was identified in the RT-PCR 
products prepared from mRNAs of lymph nodes of Ipr (lym- 
phoproliferation) mice. Lpr mice have hypertrophied lymph 
nodes comprising CD3’CD4- CD8- T cells with high expres- 
sion of the Fyn tyrosine kinase [16]. Interestingly, the level of 
tyrosine phosphorylation of the Byp protein expressed in COS7 
cells was increased by the co-expressed Fyn kinase. Therefore, 
Byp might be regulated by Fyn-mediated tyrosine phosphoryl- 
ation. 
2. Materials and methods 
2.1. CeN culture 
COS7 cells and NIH3T3 cells were cultured in DMEM supplemented 
with 10% calf serum. Murine pre-B cell line WEHI-231, T cell hybrid- 
oma HBC21.7.31, erythroid cell line F5-5 were cultured in RPM1 1640 
supplemented with 10% fetal calf serum. Myeloid cell line FDC-P2 were 
cultured in RPM11640 supplemented with 10% fetal calf serum and 
10% of WEHI- culture supernatant. 
2.2. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
Total RNA was prepared from hypertrophied lymph nodes of a 
5-month-old lpr mouse by the AGPC (guanidium cid/phenol/chloro- 
form) method [17]. The first-strand cDNA was synthesized with Super- 
Script reverse transcriptase (Gibco BRL) using a primer which is de- 
signed from an amino acid sequence within the relatively conserved 
C-terminus of the PTP domain QTX(A/E/D)Q: 5’-(A/T)(A/G) 
(CIT)TG(CIGIT)(GIT)CN(G/T)(~C/G)(C/G~)GT(C/T)TG-3’. The 
cDNA made was used as a template for PCR. A pair of degenerate 
oligonucleotide primers for PCR was designed from the conserved 
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amino acid sequences in the PTP domains DYINA and HCSAG: 5’- 
ATGAAGCTTGA(C/T)TA(C/T)AT(C/T)AA(C/T)GC-3’ and S-CA- 
TGAATTCC(A/G/T)GCACTGCA(A/G)TG-3’. respectively, having 
an Hind111 or EcoRI site at the 5’ end (underlined). PCRs were per- 
formed for 40 cycles with denaturation at 94°C for 30 s, annealing at 
45°C for 30 s, and extension at 72°C for 1.5 min. The products of the 
expected size (about 500 bp) were cloned between the EcoRI and 
Hind111 sites of pUC119 and subjected to sequence analysis by the 
dideoxynucleotide chain termination method using the BcaBest se- 
quencing kit (Takara). 
2.3. Screening of the cDNA library 
A jlgtll cDNA library was constructed from poly(A)’ RNA of 
lymph node of lpr mice using random hexamer primer. One of the 
RT-PCR products (Fig. 1, probe 1) was labeled by random priming and 
used as a screening probe. Filters representing 1 x 10” plaques were 
hybridized overnight at 42°C in 4 x SSC (1 x SSC = 0.15 M NaCIIO.0 I5 
M sodium citrate)/10 x Denhardt’s solution/50 mM HEPES (pH 7.0)/ 
50% (v/v) formamide/lOO pglml denatured salmon sperm DNA. Hy- 
bridized filters were washed in 0.1 x SSCIO. I % SDS at 50°C and autora- 
diographed. Complementary DNA fragments isolated from positive 
clones were subcloned into the pBluescript II SK(+) vector and se- 
quenced. Initial screening yielded incomplete cDNAs without ATG and 
polyA tail. Thus, the second round screening was carried out using the 
XbaI-PstI fragment of the clone I-14 (probe 2) and the XhoI-BstEII 
fragment of the clone l-2 (probe 3) as probes. 
2.4. Northern blotting 
Total RNA was extracted from normal and Ipr mice tissues and 
murine cell lines by the AGPC method. Total RNA (2Opg) was electro- 
phoresed on a 1% formaldehyde-agarose gel and transferred to a nylon 
membrane. After UV cross-linking, the blots were hybridized at 42°C 
with “P-labeled byp probe (2.6 kbp cDNA fragment from clone l-14) 
in 50% formamide/ x SSC/4 x Denhardt’s solution/50 mM sodium 
phosphate (pH 6.5)/0.2% SDS, washed at 50°C in 0.1 x SSC/ 0.1% SDS 
and autoradiographed. The blots were then re-hybridized with p-actin 
probe to verify equivalent RNA loading. 
2.5. Bacterial protein expression 
GST-Byp(p) was constructed by inserting the PvuII fragment of the 
byp cDNA encoding the PTP domain (from Ala-961 to Ala-1238) into 
the pGEX-2T expression vector (Pharmacia LKB). The Cys-1140 to Ser 
mutant, GST-Byp(p)CS, was made from GST-Byp(p) by oligonucleo- 
tide-directed mutagenesis [18]. GST-Byp(c) and GST-Byp(ex) were con- 
structed by inserting the PvuI and PvuII fragment corresponding to the 
C-terminal region (Arg-1155 to Ala-1238), and the BarnHI and 
EcoO109 fragment corresponding to the extracellular domain located 
just upstream of the transmembrane portion (Gly-721 to Asp-870), 
respectively, into the pGEX-2T vector. The GST-fusion proteins were 
expressed in Escherichia coli DH5a at 25°C overnight in the presence 
of 0.1 mM isopropyl-p-o-thiogalactopyranoside (IPTG). The bacterial 
culture was centrifuged and the pellets were resuspended in L buffer (50 
mM Tris-HCI (pH 7.5)/25% sucrose/5 mM MgC&/0.5% Nonidet P-40) 
and sonicated on ice. After centrifugation at 10,000 x g for 15 min. the 
GST-fusion proteins were purified with glutathione-agarose (Sigma) as 
described [19]. 
2.6. Analysis of the protein tyrosine phosphatase activit? 
PTP assay was performed as described [20] usingp-nitrophenyl phos- 
phate (pNPP) as a substrate. Varying amounts of the GST, GST- 
Byp(p), or GST-Byp(p)CS protein bound to glutathione-agarose beads 
were incubated at room temperature for 10 min in 200 ~1 reaction 
mixture containing 50 mM imidazole (pH 7.5), 0.1% P-mercaptoetha- 
nol, and 10 mM pNPP. The reaction was stopped with 800 ~1 of 0.25 
N NaOH, and the absorbance at 440 nm was measured. 
2.7. Polyclonal antibodies against Byp 
Rabbits were first immunized with 1 mg of the GST-Byp(c) or GST- 
Byp(ex) protein in Freund’s complete adjuvant and boosted every 
2 weeks with 0.5 mg of the antigens in Freund’s incomplete adjuvant. 
Polyclonal antibodies against Byp were affinity purified using the GST 
and GST-Byp proteins bound to CNBr-activated Sepharose 4B (Phar- 
macia). Affinity purified antibodies against GST-Byp(c) and GST- 
Byp(ex) were named anti-BypC and anti-BypEx, respectively. 
2.8. Trunsient elcpression. immunoblotting, and immunoprecipitution 
A b?F expression vector, pME-byp, was constructed by cloning a 
cDNA fragment encoding the entire open reading frame of bj>p (com- 
bined the cDNA sequences of clones 2-21 and I-14) into an eukaryotic 
expression vector, pME18S [21]. Each plasmid DNA was transfected 
into COS7 cells (1 x IOh per 10 cm dish) by the calcium phosphate 
method. After 48 h of transfection, the cells were lysed in TNE buffer 
(50 mM Tris-HCI (pH 8.0)/l% NP-40/20 mM EDTA) containing so- 
dium orthovanadate (I mM) and aprotinin (50 units/ml). The proteins 
in the lysates from 1 x lo5 cells or the precipitates by the anti-BypC 
antibody were fractionated by 7.5% SDS-PAGE under reducing condi- 
tions and transferred to Immobilon-P membrane (Millipore). The pro- 
teins reacted with the probe were visualized with ECL detection kit 
(Amersham) or ProtBlot Western AP system (Promega). For metabolic 
labeling. the cells were cultured for 12 h in methionine-free DMEM 
supplemented with 10% (v/v) dialyzed calf serum and 20 &i/ml 
[7’S]methionine (ICN). The cells were then washed in serum-free 
DMEM and lysed in TNE buffer containing aprotinin at 4°C. Cell 
lysates were precleared with protein A-Sepharose 4B (Pharmacia LKB) 
for 30 min and incubated with anti-BypC for 2 h at 4°C. The immune 
complexes were precipitated with protein A-Sepharose, washed five 
times with TNE buffer, and analyzed by 7.5% SDS-PAGE and autora- 
diography. 
2.9. In situ hybridization 
The direct R-banding FISH (Juorescence in situ hybridization) 
method was used for chromosomal assignment of the byp gene on 
mouse and rat chromosomes. Preparation of R-banded chromosomes 
and FISH were performed as described [22]. Briefly, the chromosome 
slides were hardened at 65°C for 2 h, and then denatured at 70°C in 
70% formamide in 2 x SSC, and dehydrated in 7&85~100% ethanol at 
4°C. The 4.2 kbp mouse byp cDNA fragment was labeled by nick 
translation with biotin 16-dUTP (Boehringer-Mannheim) following the 
manufacture’s protocol. The fluorescence signals of hybridized probes 
were amplified with anti-biotin antibody (Vector), fluorescein anti-goat 
IgG (Nordic Immunology) and propidium iodide. Excitation at wave- 
length 450490 nm (Nikon filter set B-2A) and near 365 nm (UV-2A) 
were used for observation. 
3. Results 
3. I. Isolution and sequence analysis of hyp cDNA 
Lpr mice have hypertrophied lymph nodes comprising CD4- 
CD8- T cells which express high level of the Fyn protein- 
tyrosine kinase [16]. Assuming that expression of some PTPs 
may be induced in lpr mice to counteract the overexpressed Fyn 
tyrosine kinase, we searched for a novel PTP expressed in the 
lymph nodes of lpr mice. For this purpose, we employed the 
RT-PCR method with the primers for the conserved PTP do- 
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Fig. 1. Overlapping byp cDNA clones and a diagram of the complete 
cDNA structure. Untranslated sequences are represented by a line and 
coding sequences are boxed; shaded boxes represent sequences for the 
putative signal peptide (S), the transmembrane domain (TM), and the 
PTP domain (PTP). The dotted lines indicate the cDNA fragments used 
as probes for library screening and the open bars represent the four 
overlapping clones. Restriction map of the byp cDNA is shown at the 
top: E, EcoRI; K, KpnI; Xb. XbaI; Ba, BarnHI; P, PstI; EO, Ec00109; 
Xh, Xhol; PI, PvuI; Pv, PvuII; Bs, BstEIl. 
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FTSWPDHGVP D'PTDLLINFR YLVRDYMKQI PPESPILVH~VGRTGTF 
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Fig. 2. Amino acid sequence of Byp. The putative signal peptide is 
double-underlined and the transmembrane region is single-underlined. 
A segment of each predicted FN-III motif is bracketed with an outlined 
number designating each domain. Potential N-glycosylation sites are 
indicated by dots. The sequences used to design the PCR primers are 
indicated by arrows, The phosphatase domain is boxed, and predicted 
amino acid sequence is numbered on the right. 
main and mRNAs from the T cells of lpr mice. PCR amplifica- 
tion yielded about 500-bp fragments that were subsequently 
cloned into pUCl19. Nucleotide sequencing of the cDNA in- 
serts from 52 clones resulted in the identification of 9 clones 
containing cDNAs for a novel PTP. Using an insert from one 
of the clones as a probe (Fig. 1, probe l), we screened a ilgtl 1 
cDNA library from lymph nodes of Ipr mice at high stringency 
and obtained 10 positive clones. Restriction mapping analysis 
of the 10 clones revealed that clone l-2 and clone l-14 included 
the sequences of the other 8 clones. The nucleotide sequences 
of clones l-2 and 1-14 showed that the cDNA inserts of these 
two clones did not contain a translation initiation codon or a 
poly(A) tail. In order to obtain further upstream and down- 
stream sequences, the same cDNA library was screened with 
an X&l-&I fragment of clone 1-14 (Fig. 1, probe 2) and an 
XhoI-BstEII fragment of clone l-2 (Fig. 1, probe 3). Several 
overlapping clones including clone 2-22 and clone 3-25 were 
identified as positives (Fig. 1). After determination of the nucle- 
otide sequences of these clones (clones 1-2, 1-14, 2-22, and 
3-25) a putative open reading frame of byp was pieced together 
from the four overlapping cDNA fragments (Fig. 1). The Byp 
protein was then predicted to consist of 1238 amino acids, 
calculated molecular weight being 134,000. The deduced amino 
acid sequence is shown in Fig. 2. The Byp protein comprises 
9 
a stretch of 28-hydrophobic amino acids, which may serve as 
a signal peptide, at the extreme amino-terminus, followed by 
an 842-amino acid extracellular domain, a 26-amino acid hy- 
drophobic transmembrane domain, and a 342-amino acid cyto- 
plasmic region containing a single PTP domain. The PTP do- 
main of Byp shows high homology to that of type III RPTPs 
such as DEP-1 (97% amino acid identity), HPTPP (59%) 
DPTPlOD (52%). SAP-l or GLEPPl (50%) (Fig. 8A). These 
data suggest that Byp belongs to type III RPTP family. Indeed, 
like other members of type III RPTPs, Byp contained multiple 
(eight) fibronectin type III (FN-III)-like repeats and no immu- 
noglobulin (Ig)-like domains in the extracellular region. It also 
had a single PTP domain in the cytoplasmic region. Note that 
other types of RPTPs all contain tandemly repeated PTP do- 
mains. 
3.2. Expression of byp in tissues and cell lines 
To analyze the expression level of the byp mRNA in mouse 
tissues and cell lines, we performed Northern blotting experi- 
ments using the 32P-labeled DNA insert of clone l- 14 as a 
probe. As shown in Fig. 3A, a 7.7-kb byp mRNA was expressed 
at higher level in the brain, kidney and spleen and at lower 
levels in the other tissues. Though byp cDNA was originally 
isolated from lymph nodes of lpr mice, byp expression was not 
high in this tissue. We also examined the expression of byp in 
several murine cell lines, and showed that the byp mRNA was 
not detectable in fibroblasts (NIH3T3) and erythroid (F5-5) 
cells, but was expressed at relatively elevated level in myeloid 
(FDCP2) cells and lower level in pre-B lymphoid (WEHI-231) 
and T hybridoma (HBC21.7.31) cells (Fig. 3B). 
3.3. Demonstrution of the PTP activity of Byp 
To demonstrate the PTP activity of Byp, the cDNA fragment 
encoding the putative PTP domain was subcloned into the 
pGEX-2T vector. The fusion protein encoded by the resulted 
plasmid was termed GST-Byp(p) and was purified from bacte- 
rial lysates. The purified protein were incubated with p-nitro- 
phenyl phosphate (pNPP) and assayed for the PTP activity 
(Fig. 4). The GST-Byp(p) protein but not GST was able to 
dephosphorylate pNPP. Hydrolysis of pNPP by GST-Byp(p) 
was inhibited in the presence of 1 mM sodium orthovanadate, 
a specific inhibitor of PTPs, suggesting that Byp carried the 
PTP activity. In addition, we showed that a CS mutant, GST- 
Byp(p)CS, in which a catalytically obligatory cysteine residue 
at position 1140 was mutated to serine, did not exhibit the PTP 
activity (Fig. 4). 
3.4. Transient expression of Byp in COS7 cells 
To analyze the protein product of byp, a rabbit polyclonal 
antibodies were raised against the GST-Byp(c) protein contain- 
ing carboxy-terminal tail of Byp or the GST-Byp(ex) protein 
containing the extreme amino-terminal sequence of Byp (see 
section 2). As shown in Fig. 5A, anti-Byp(c) could specifically 
detect a 220 kDa protein in the lysates of COS7 cells transfected 
with the byp expression plasmid, pME-byp (lane 3). The 220- 
kDa Byp protein was also detected by immunoprecipitation 
with anti-Byp(c) from the byp-transfected COS7 cells metabol- 
ically labeled with [35S]methionine (Fig. 5B). Byp is thought to 
be a glycoprotein, since it contains 37 potential sites for N- 
linked glycosylation in the extracellular region (Fig. 2). Treat- 
ment of byp-transfected cells with tunicamycin, which inhibits 
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Fig. 3. Expression of the byp mRNA in normal and ipr mouse tissues and in murine cell lines. Twenty pug of total RNA prepared from the indicated 
tissues (A) and from different murine cell lines (B) were analyzed by Northern blotting. Filters were sequentially hybridized with the “P-labeled cDNA 
insert of clone l-14 (byp probe) (top) and with a p-actin probe (bottom). Positions of 28s and 18s rRNA are indicated on the left. 
addition of N-linked oligosaccharides at asparagine residues, 
reduced the apparent molecular mass of Byp to about 130 kDa 
(Fig. 5A, lane 4). Since the calculated molecular weight of Byp 
is 134,000, these data indicate that Byp is highly N-linked gly- 
cosylated. O-Linked glycosylations may be poorly occurring. 
Western blotting analysis showed that the size of Byp expressed 
in different tissues or cells slightly differed from each other (200 
kDa in the brain, 250 kDa in the spleen, 220 kDa in 
HBC21.7.31 and 250 kDa in FDC-P2) (data not shown), which 
may be due to the different degree of glycosylation. 
3.5. Tyrosine phosphorylation of Byp 
Several lines of evidence suggest that PTPs may be regulated 
by tyrosine phosphorylation [23,24]. Tyrosine-phosphorylated 
PTPs may play a role in assembling multiprotein complexes 
through phosphotyrosine-SH2 (Src homology 2) interaction 
[23,25]. To examine whether the Byp protein is tyrosine 
phosphorylated or not, immunoblot analysis with anti- 
phosphotyrosine antibody was performed. As shown in Fig. 6, 
tyrosine phosphorylation of Byp was detected only after treat- 
ment of cells with a potent phosphatase inhibitor, pervanadate 
(1 mM hydrogen peroxide and 1 mM sodium orthovanadate) 
(lanes 2, 3). Since Byp was first identified in lymph node of lpr 
mice where the expression of Fyn tyrosine kinase is highly 
enhanced, we speculated that Byp might be tyrosine 
phosphorylated by Fyn. To examine this possibility, we co- 
transfected the byp and fyn expression plasmids into COS7 
cells, and found that expression of Byp together with Fyn 
dramatically increased the level of Byp tyrosine phosphoryla- 
tion (Fig. 6). Co-expression of Byp and Fak, another member 
of PTKs, had no effect on tyrosine phosphorylation of Byp 
(data not shown), suggesting that Byp can be phosphorylated 
by only a subset of PTKs. 
3.6. Chromosomal localization of‘ the byp gene 
The chromosomal localization of the mouse and rat byp gene 
was determined by direct R-band FISH using the mouse byp 
cDNA fragment as a probe. As shown in Fig. 7, the signals were 
located on the El-2 band of mouse chromosome 2 and on the 
GST-EWP) 
GST-Byp(p)+Vanadate 
GST-Byp(p)CS 
GST 
0 2 4 6 8 10 
GST (fusion) protein (pg) 
Fig. 4. PTP activity of the GST-Byp(p) fusion protein. The PTP activ- 
ities of GST-Byp(p), GST-Byp(p) CS, and GST were assayed using 
p-nitrophenyl phosphate (pNPP) as a substrate. Dephosphorylation of 
pNPP was measured by the absorbance at 410 nm. The phosphatase 
activity of GST (o), GST-Byp(p)CS (A), or GST-Byp(p) in the presence 
(0) or absence (0) of 1 mM sodium orthovanadate is shown. The result 
shown is a representative of the three independent experiments. 
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Fig. 5. Identification of the Byp protein. (A) Detection of Byp expressed in COS7 cells by immunoblotting. COS7 cells were transfected with pME-byp 
expression vector (lanes 3 and 4; byp) or empty vector (lanes 1 and 2; mock). After 24 h of transfection, the transfectants were cultured in the presence 
(lanes 2 and 4; +) or absence (lanes 1 and 3; -) of tunicamycin (1 mg/ml) for additional 24 h, and lysed. The proteins in the lysates were fractionated 
by 7.5% SDS-PAGE and immunoblotting with anti-BypC antibody. (B) Immunoprecipitaion of Byp expressed in COS7 cells. COS7 cells were 
transfected with pME-byp (lane 1; byp) or empty vector (lane 2; mock). The metabolically labeled protein in the lysates were immunoprecipitated 
with anti-BypC and the immunoprecipitates were analyzed by 7.5% SDS-PAGE followed by autoradiography. Molecular mass markers are indicated 
in kilodaltons on the left. Arrows indicate the positions of the Byp protein. 
q32-33 band of rat chromosome 3. These regions are included 
in a large segment in which conserved linkage homology has 
been identified between the two species [22]. They correspond 
to the pl 1- 13 region of human chromosome 11, where deletion 
is frequently observed in human cancers such as breast, liver, 
and bladder carcinomas [26-281. 
4. Discussion 
We have cloned a mouse transmembrane-type PTP termed 
Byp that contains a single PTP domain in the cytoplasmic 
region and eight FN-III domains and no Ig-like domains in the 
extracellular region. From the structural characteristics, Byp 
was classified as a member of type III RPTPs, which include 
DEP-1 (HPTPq), HPTPB, SAP-l, GLEPPl, PTP-U2 and 
DPTPlOD. Comparison of amino acid sequences of these pro- 
teins reveals that Byp is most homologous to human DEP-1 
showing 95% amino acid identity in the cytoplasmic region and 
63% identity in the extracellular region. Like murine Byp and 
human DEP- 1, human SAP- 1 and PTP-U2 that belong to type 
III RPTP subfamily also carry eight FN-III domains. However, 
the extracellular domains of these PTPs show much less homol- 
ogy to Byp than DEP-1 (Fig. 8B). It is noteworthy that the 
sequences at the extracellular domains of some receptor-like 
proteins significantly vary between species [29]. The byp gene 
was mapped to the region El-2 of mouse chromosome 2 and 
q32-33 of rat chromosome 3 (Fig. 7). This region corresponds 
to the region pl 1- 13 of human chromosome 11. Recently, the 
HPTP?,J gene was also mapped to p 11.2 of human chromosome 
11 [12]. The chromosome mapping data together with high 
degree of sequence identity suggest that Byp is a mouse homo- 
logue of DEP-1 (HPTPq). 
Immunoblotting and immunoprecipitation analyses showed 
that the apparent molecular mass of Byp is about 220 kDa (Fig. 
5), though its calculated molecular weight is 134,000. The ap- 
parent difference is largely due to the glycosylation of the Byp 
protein, because tunicamycin treatment entirely reduces the 
size of Byp to 130 kDa (Fig. 5). The degree of modification of 
Byp by sugar chains differs among organs and cell lines, the size 
of Byp being between 220 kDa and 250 kDa (data not shown). 
Whether the difference in the degree of glycosylation has any 
effect on its PTP activity and/or its ligand specificity remains 
to be seen. 
All PTPs contain the conserved amino acid motif (IN)HCX- 
AGXGR(S/T)G located near the carboxyl-terminus of the 
phosphatase domain. Biochemical studies have established that 
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Fig. 6. Tyrosine phosphorylation of the Byp protein. COS7 cells &ere 
transfected with 7 pg of empty vector (lane I), 7 pg of pME-6~7) (lanes 
2 and 3). 7 pg of pME-byp and 5 pug of pME-j$n [21] (lane 4). Two days 
after transfection, cells were treated with 1 mM sodium orthovanadate 
and I mM hydrogen peroxide for 10 min (lanes 1, 3 and 4) and lysed 
in TNE buffer. The proteins immunoprecipitated with anti-BypC were 
analyzed by immunoblotting with anti-BypEx antibody (left) or anti- 
phosphotyrosine antibody, PY-20 (ICN) (right). The arrow indicates 
the position of the Byp protein. 
the cysteine residue within this consensus motif is essential for 
the PTP activity and forms a covalent thiol-phosphate bond 
with the phosphorylated tyrosine residue in the substrate [4.30]. 
Mutation of this cysteine results in complete loss of the PTP 
activity [31]. Indeed, the GST-Byp(p)CS protein containing a 
Cys to Ser mutation at position 1140 of Byp shows no PTP 
activity (Fig. 4). PTPs with the Cys to Ser mutation have been 
reported to associate stably with their substrates. For example, 
the Cys to Ser mutants of 3CHl34 and CD45 well associate 
with ~44~~~~ [32] and the CD31 chain [33], respectively. There- 
fore, the Cys to Ser mutant could help identify the substrate of 
each PTP. The tight association between the Cys to Ser mutant 
of Byp and the Fyn kinase was observed in COS7 cells (unpub- 
lished data), suggesting their functional interaction. We also 
demonstrated that the Byp protein expressed in COS7 cells was 
tyrosine phosphorylated, and co-expression of the Fyn tyrosine 
kinase dramatically increased tyrosine phosphorylation of Byp. 
The Fyn kinase is highly expressed in the unusual CD4- CD8- 
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T-cells of lymph node of lpr mice [ 161. Thus, it is likely that Byp 
is highly tyrosine phosphorylated in the lymphocytes of lpr mice 
and thereby the activity of Byp may be modulated in these cells. 
Recent reports demonstrate that tyrosine phosphorylation of 
PTPs is involved in regulation of their activity. PTPlC (also 
known as SH-PTPl, HCP, or SHP) is directly phosphorylated 
on two tyrosine residues by Lck [24]. CD45 is tyrosine 
phosphorylated by CSK and tyrosine phosphorylation of 
CD45 causes an increased PTP activity and its association with 
the SH2 domain of Lck [23]. It is also known that SH-PTP2 
(also known as PTPlD, PTP2C, SH-PTP3, or Syp) binds via 
its SH2 domain to phosphotyrosines on the platelet-derived 
growth factor receptor, epidermal growth factor receptor and 
IRS-l in response to the extracellular stimuli. In addition, li- 
gand stimulation of these receptors induces tyrosine phospho- 
rylation of SH-PTP2 [3&37]. Therefore, it is likely that tyrosine 
phosphorylation of Byp alters its PTP activity and/or cause 
association with various SH2- or PTB (phosphotyrosine bind- 
ing domain)-containing molecule(s) [38,39], leading to activa- 
tion of downstream signaling. 
Type III RPTPs show high degree of sequence similarity with 
each other in their cytoplasmic regions compared with other 
types of RPTPs. They may have evolutionary conserved func- 
tion in intracellular signaling. We show here that Byp is 
phosphorylated on tyrosine residues. There are twenty tyrosine 
residues within the intracellular region of Byp. The intracellular 
domains of DEP-1, HPTPj?, and GLEPP-1 also contain many 
tyrosine residues which might be tyrosine phosphorylated. An 
Y EN(LN) amino acid motif is conserved in the carboxyl-termi- 
nus of these RPTPs. This motif is a potential binding site of the 
SH2 domain of the 3BP2 protein [40]. In addition to the SH2 
domain, 3BP2 contains a proline-rich domain and a plekstrin- 
homology (PH) domain, which implies its participation in sig- 
nal transduction [41]. Thus, the 3BP2 protein might mediate 
signaling downstream of type III RPTPs. Although the role of 
Byp in cellular signaling is yet to be established, the present data 
should provide clues to unravel the biological significance of 
RPTPs including Byp. 
Fig. 7. Chromosomal localization of the byp gene. A 4.2 kbp mou\e byp cDN.4 fragment was used as a biotinylated probe for in situ hybridization 
on mouse and rat R-banded chromosomes. The hybridization signals are indicated by arrows. The signals are located on 2E1-2 band of mouse 
chromosome 2 (a,c) and q32-33 band of rat chromosome 3 (d,l). The metaphase spreads were photographed with Nikon B-2A (a, b and d-f) and 
UV-2A (c) filters. R-band and G-band patterns are demonstrated in (a, c, d and t) and (b, e), respectively. 
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KCVEQGRTKCEEYWP SKQAQDYGDITVAMTSEWLPEWTIRD~ QNSESHPL RQFHFTSWPDHGVP DTTDLLI 
_____--_-___-_- -__-_---_________I__-----___T---I_T-_-I_T-_---- ______--______ _-_--__ 
Q---K--V--DH-_-~DSLY-_~LILQ-L--S-_---__---_-~~~~~~~~~~Q~~~~~~~-H--Y-V-----~- E--QS-- 
N-M-A--V---H---LDS-PCTH-HLRVTLVG-E-MEN--V-ELLLLQVEEQKTLS V----YQA------- SSP-T-L 
Q-N-KR-V--DH---FTEEPIA------E-I--EEQDD-AC-H-RI~~~QD VMH-NY-A-------TANAAESIL 
Q-N-KR-V--DH---FTEEPIA------E-I--EEQDD-AH-H-RINYADEMQD VMH-NY-A-------TANAAESIL 
R-F-K--E--DQ---NDTVPVF----K-QILNDSHYAD-VMTE-MLCRGSEQ RIL-H----T---F--- NPPQT-V 
VGM-N--VL--H---ANSTPVTH-H--IHLLA-EPED---R-E-QLQHGTEQKQRR VK-LQ--T----S-- EAPSS-L 
NFRYLVRDYMKQIPPESPILVHCSAGVGRTGTFIAIDRLIYQIENENTVDVYGIVYDLRMHRPLMVQTEDQWFLNQCVL 
Extracellular Intracellular 
l-l 
DEP-1 (h) 63 % 95 % 
SAP-1 (h) 27 43 
PTP-U2 (h) 20 46 
Fig. 8. Comparison of Byp with other type III RPTPs. (A) Sequences of the catalytic domain of the following PTPs are aligned: Byp, DEP-1 [I I]. 
SAP-1 [lo], PTP-LIZ [15], GLEPPl [13], DPTPIOD [8,9], and OST-PTP [14]. The numbers in parentheses indicate the amino acid positions. Dashes 
indicate amino acid residues identical to those of Byp. (B) Schematic representation of the predicted Byp protein showing the FN-III motifs (dotted) 
and the PTP domain (hatched). The numbers indicate the percent amino acid identity at the extracellular domain and cytoplasmic domain between 
Byp and each PTP that carries eight FN-III motifs. m = mouse; h = human. 
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